Formula-based dosing for carboplatin

被引：7

作者：

Jodrell, DI ^{[1
]}

机构：

[1] Univ Edinburgh, Western Gen Hosp, Imperial Canc Res Fund, Med Oncol Unit, Edinburgh EH4 2XU, Midlothian, Scotland

来源：

EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷 / 09期

关键词：

D O I：

10.1016/S0959-8049(99)00127-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：1299 / 1301

页数：3

共 16 条

[1]

Calvert A. Hilary, 1997, Seminars in Oncology, V24, P85

[2]

CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION [J].

CALVERT, AH ;

NEWELL, DR ;

GUMBRELL, LA ;

OREILLY, S ;

BURNELL, M ;

BOXALL, FE ;

SIDDIK, ZH ;

JUDSON, IR ;

GORE, ME ;

WILTSHAW, E .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1748-1756

[3]

PREDICTION OF CARBOPLATIN CLEARANCE FROM STANDARD MORPHOLOGICAL AND BIOLOGICAL PATIENT CHARACTERISTICS [J].

CHATELUT, E ;

CANAL, P ;

BRUNNER, V ;

CHEVREAU, C ;

PUJOL, A ;

BONEU, A ;

ROCHE, H ;

HOUIN, G ;

BUGAT, R .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (08) :573-580

[4]

PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].

COCKCROFT, DW ;

GAULT, MH .

NEPHRON, 1976, 16 (01) :31-41

[5]

DAUGAARD G, 1988, CANCER CHEMOTH PHARM, V21, P163

[6]

EGORIN MJ, 1984, CANCER RES, V44, P5432

[7]

EGORIN MJ, 1985, CANCER RES, V45, P6502

[8]

GORE ME, 1996, P AM SOC CLIN ONCOL, V15, pA769

[9]

JELIFFE RW, 1973, ANN INTERN MED, V79, P604

[10]

RELATIONSHIPS BETWEEN CARBOPLATIN EXPOSURE AND TUMOR RESPONSE AND TOXICITY IN PATIENTS WITH OVARIAN-CANCER [J].

JODRELL, DI ;

EGORIN, MJ ;

CANETTA, RM ;

LANGENBERG, P ;

GOLDBLOOM, EP ;

BURROUGHS, JN ;

GOODLOW, JL ;

TAN, S ;

WILTSHAW, E .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) :520-528

← 1 2 →